The global prevalence of NAFLD was estimated at 32.4% (95% CI 29.9–34.9), with male predominance and an increasing trend over time [ 9 ].
← all excerpts
Tocotrienol in the Management of Nonalcoholic Fatty Liver Disease: A Systematic Review.
1
—
—
The global prevalence of NAFLD was estimated at 32.4% (95% CI 29.9–34.9), with male predominance and an increasing trend over time [ 9 ].